The bioinformatics market is expected to grow from US$ 12,609.39 million in 2021 to US$ 34,749.78 million by 2028; it is estimated to grow at a CAGR of 15.7% from 2022 to 2028.
Data Bridge Market Research analyses that the AI in bioinformatics market is expected to reach the value of USD 37,027.96 million by 2029, at a CAGR of 42.7% during the forecast period. “Services" accounts for the largest technology segment in the AI in bioinformatics market due to rapid developments in technological pathways to commercialize the use of handheld AI in bioinformatics. The AI in bioinformatics market report also covers pricing analysis, patent analysis and technological advancements in depth.
Over the past decade, the demand for bioinformatics has escalated as they bridge the gap between the biological information and technology for efficient storage, analysis, and distribution of data across healthcare centers. Bioinformatics makes use of software applications for systematic data management, warehousing, mining along with database creation, and plays a vital role in biomedicine development. During the COVID-19 pandemic, the global bioinformatics market witnessed a spike in the adoption owing to the ability to store and manage data in huge volumes. For More Information of Bioinformatics Market Visit: https://www.fairfieldmarketresearch.com/report/bioinformatics-market
Major players in the synthetic biology market are Thermo Fischer Scientific, Genscript, Integrated DNA Technologies, Amyris....@ @ https://bit.ly/3oeZ8Zv
Goldstein Research analyst forecast the Bioinformatics Market size is set to reach USD 17.5 billion by 2024, at a CAGR of 20.5% over the forecast years.
The report segments the global bioinformatics market by sectors, products and services, application and geography. Knowledge management tools accounted for the largest share of the global bioinformatics market, by product and services in 2014. However, Bioinformatics platforms are expected to grow at the highest CAGR during the forecast period. See Full Report: http://bit.ly/1z5gdbN
Bioinformatics Market size was valued at $8.3 billion in 2020, growing at a CAGR of 12.4% during the forecast period 2021-2026. The recording, annotation, storage, analysis, and retrieval of nucleic acid sequence, protein sequence, and structural information are all covered by bioinformatics. Proteomics is the study of proteomes on a vast scale. A proteome is a collection of proteins made by a living creature, system, or biological milieu. Single nucleotide polymorphisms (SNPs) is a useful tool for determining the genetic basis of disease. In genome-wide association studies and fine-scale genetic mapping initiatives, these variants can be utilized as markers.
Diabetic foot ulcer is a type of chronic wound that often leads to complications and challenges surgeons to manage such injuries. Diabetic foot ulcer leads to full thickness skin loss on the foot due to neuropathic and/or vascular complications in patients with type 1 or type 2 diabetes mellitus. Diabetic patient who uses insulin are at a higher risk of developing a foot ulcer.
Global genotyping assay market size is expected to reach $77.77 Bn by 2028 at a rate of 23.0%, segmented as by product and service, reagents and kits, genotyping services, instruments, bioinformatics
The global bioinformatics market size is expected to grow from $11.55 billion in 2021 to $13.02 billion in 2022 at a compound annual growth rate (CAGR) of 12.7%.
Bioinformatics Market report categorizes the global market by Application (Genomics, Proteomics & Drug Design) By Sector (Molecular Medicine, Agriculture, Research & Forensic), Segment (Sequencing Platforms, Knowledge Management Tools & Data Analysis Services) & by Geography
Latest research report “Bioinformatics Market” published by TBRC provides Market Analysis Forecast, Size, Trends, Key Players, Segments and Growth. Read Full Report: http://bit.ly/2lyDCSP Request a Sample: http://bit.ly/2kqQLgz
The Biosimulation Market Report provides a comprehensive analysis of the global Biosimulation market, highlighting key trends, drivers, challenges, and opportunities shaping the industry.
Metabolomics Global Market Report 2020 is the latest research report added to The Business Research Company database. The report is covered in 200 pages covering 5 major players in the industry.
Data Bridge Market Research analyses that the AI in bioinformatics market is expected to reach the value of USD 37,027.96 million by 2029, at a CAGR of 42.7% during the forecast period
The Bioinformatics Market research report covers key players, trends, status, future forecast, size-share, development trends, challenges, opportunities and consumer behavior’s. It provides insight into the growth of value players, as well as looking at new entrants to the market and their growth prospects.
In 2018, the global market for bioinformatics services registered the revenues worth US$ 1.9 Bn. Spectacular growth in the deployment of bioinformatics services is likely to offer a strong impetus to the global market value in 2019, at an estimated 13% Y-o-Y growth rate.
According to a new market report published by Persistence Market Research “Global Market Study on Bioinformatics – Asia to Witness Fastest Growth by 2020,” the global bioinformatics market was valued at USD 4,110.6 million in 2014 and is expected to grow at a CAGR of 20.4% from 2014 to 2020, to reach an estimated value of USD 12,542.4 million in 2020.
The global metabolomics market size is expected to grow from $2.35 billion in 2021 to $2.69 billion in 2022 at a compound annual growth rate (CAGR) of 14.6%.
Get more details @ http://bit.ly/2l3rNQ4 Key industry players contributing to global precision medicine market share include Pfizer, Roche, Covance, Novartis, Qiagen, Biocrates Life Sciences, Teva Pharmaceutical, Nanostring Technologies, Laboratory Corporation of America Holdings, Tepnel Pharma Services, Intomics, Ferrer InCode, Silicon Biosystems, Eagle Genomics, Medtronic, and Quest Diagnostics
The market for drug discovery software (such as ligand-based design, structure-based design, LIMS, ELN) is driven by rising R&D spend and pipeline, expanding scope and scale, increasing stringency of testing and regulations, growing number and size of biotechs, need for increasing cost efficiencies and reducing time to market, and the shift to web/cloud-based software.
... for Nonparametric Statistics. Michael J. Schell. Moffitt Cancer ... Chernoff and Savage (1958) proved that the ARE of the normal scores test is at least 1 ' ...
Europe Bioinformatics Market By Industry (Molecular Medicine, Drug Development, Clinical Diagnostics, Agriculture, Forensic, Animal, Academics & Research, Environmental, Gene Therapy), By Product Type (Sequencing Platforms, Knowledge Management Tools, Bioinformatics Software), By Application (Preventive Medicine, Molecular Medicine, Genomics, Drug Development, Transcriptomics, Others), By Services (Data Analysis, Sequencing, Database integration, Others), By Country (Germany, France, U.K., Spain, Italy, Russia, Netherlands, Turkey, Belgium, Switzerland, Rest of Europe) – Trend and Forecast to 2024
A recent report published by TheBusinessResearchCompany on Bioinformatics Market provides in-depth analysis of segments and sub-segments in the global as well as regional. http://bit.ly/30k54E5
The global precision medicine market is expected to grow from $62.75 billion in 2020 to $72.58 billion in 2021 at a compound annual growth rate (CAGR) of 15.7%.
In 2018, the global market for bioinformatics services registered the revenues worth US$ 1.9 Bn. Spectacular growth in the deployment of bioinformatics services is likely to offer a strong impetus to the global market value in 2019, at an estimated 13% Y-o-Y growth rate.
According to a new market report published by Persistence Market Research “Global Market Study on Bioinformatics – Asia to Witness Fastest Growth by 2020,” the global bioinformatics market was valued at USD 4,110.6 million in 2014 and is expected to grow at a CAGR of 20.4% from 2014 to 2020, to reach an estimated value of USD 12,542.4 million in 2020.
The rising incidences of chronic diseases globally coupled with the increasing demand of advanced drugs for the diagnosis of these diseases are expected to propel the bioinformatics market growth.
The major players in the precision medicine market are Qiagen, Novartis AG, Medtronic, AstraZeneca plc., Quest Diagnostics, Thermo Fisher Scientific Inc...@@ https://bit.ly/2XCz1CE
According to #TechSci Research report on Global Radiomics Market would potentially project an impressive growth in the forecast period, 2022-2026, with an impressive CAGR on the account of increasing number of chronic diseases. Gain More Insight: https://bit.ly/3GyuAu3 Get Sample Report: https://bit.ly/3CtzC8C Website: https://www.techsciresearch.com/ Market Research News: https://techsciblog.com/
The global bioinformatics market was valued at USD 4,110.6 million in 2014 and is expected to grow at a CAGR of 20.4% from 2014 to 2020, to reach an estimated value of USD 12,542.4 million in 2020.
According to a new market report published by Persistence Market Research “Global Market Study on Bioinformatics – Asia to Witness Fastest Growth by 2020,” the global bioinformatics market was valued at USD 4,110.6 million in 2014 and is expected to grow at a CAGR of 20.4% from 2014 to 2020, to reach an estimated value of USD 12,542.4 million in 2020.
Increasing prevalence of cancer will surge the demand in future. As per WHO prediction, deaths due to cancer will escalate up to 13 million by 2030. The technology of biochip is extremely helpful in cancer drugs development. In addition, the research conducted and some ongoing research studies along with appropriate funding provided by private and government organizations is propelling business growth. For instance, in 2012, the Institute of Bioengineering and Nanotechnology of Singapore developed miniaturized biochip to help in detection of resistant drug for cancerous cells.
The global bioinformatics market was valued at USD 4,110.6 million in 2014 and is expected to grow at a CAGR of 20.4% from 2014 to 2020, to reach an estimated value of USD 12,542.4 million in 2020.
According to a new market report published by Persistence Market Research “Global Market Study on Bioinformatics – Asia to Witness Fastest Growth by 2020,” the global bioinformatics market was valued at USD 4,110.6 million in 2014 and is expected to grow at a CAGR of 20.4% from 2014 to 2020, to reach an estimated value of USD 12,542.4 million in 2020.
In 2018, the global market for bioinformatics services registered the revenues worth US$ 1.9 Bn. Spectacular growth in the deployment of bioinformatics services is likely to offer a strong impetus to the global market value in 2019, at an estimated 13% Y-o-Y growth rate.
The Clinical Decision Support Market Report offers a complete picture of industry trends and factors along with quantitative data based on historical data and from various sources. Apart from this, the report also provides the market outlook, growth, share, size, opportunity and forecast during 2019-2025. Further, the report focuses on competitive landscape including company profiles of leading key players along with industry demand, future capacities, key mergers & acquisitions, financial overview in the global market of clinical decision support.
Synthetic Biology Market is worth USD 2.64 billion in 2014 and is expected to reach USD 37.21 billion by 2022, at a CAGR of 27.7% from 2014 to 2022. Browse report : https://www.scalarmarketresearch.com/market-reports/synthetic-biology-market
Get more details @ http://bit.ly/2ekRPfD Some of the major players of global precision medicine market are Intomics, F. Hoffmann-La Roche, NanoString Technologies, Laboratory Corporation of America Holdings, Biocrates Life Sciences, Teva Pharmaceutical, Tepnel Pharma Services, Novartis, Silicon Biosystems, Quest Diagnostics and Ferrer InCode.
Goldstein Research analyst forecast the digital genome market size is set to reach USD 24.3 billion by 2025, at a CAGR of 8.78% over the forecast years
Government & private sector organizations for bioinformatics are some of the key factors which are triggering the growth of bioinformatics market over the forecast period.
Big Market Research has announced a new Report Package "Global Bioinformatics Market- Types, End Users, Size, Share, Trends, Forecast, Development, Situation, Future outlook, Potential" Get Complete Details At:http://www.bigmarketresearch.com/global-bioinformatics-2015-2019-market Bioinformatics is a field of science that includes computational analysis of biological data, which consists of information stored in DNA form and protein sequences in various biological databases. Biology, information technology, and computer science merge into single discipline in bioinformatics. This field is deep rooted in molecular biology and surrounds subject areas from structural biology, genomics to gene expression studies. Enquire About This Report at: http://www.bigmarketresearch.com/report-enquiry/227986
Collaboration of IT companies with bioinformatics companies is another growth propeller for this market. For More Information Visit - http://www.grandviewresearch.com/industry-analysis/bioinformatics-in-ivd-testing-market
The report on Drug Discovery Technologies Market by technology type (biochips, high throughput screening, pharmacogenomics, genomics, bioanalytical instruments, bioinformatics, nanotechnology), end users (biopharmaceutical, pharmaceutical, research institutes and biotech companies) trends analysis and forecasts up to 2024 studies the market sizes, key trends and opportunities in the main geographies such as North America, Europe, Asia-Pacific, Rest of the World. According to the report the Global Drug Discovery Technologies Market is projected to grow at a CAGR of 18.4% in terms of value over the period of 2018-2024. The growth in the world market is primarily driven by significant contribution by North America (Leading region) region to this market.